SONAL SANGHVI: Open Payments
NPI 1689853111 · MOLINE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$992 in 29 payments from 12 companies in 2025. Trend: 2023 $209 · 2024 $295 · 2025 $992
Food & beverage: $992
| Company | Payments | Amount |
|---|---|---|
| AtriCure, Inc. | 6 | $348 |
| Actelion Pharmaceuticals US, Inc. | 2 | $134 |
| Incyte Corporation | 1 | $127 |
| Novartis Pharmaceuticals Corporation | 4 | $80 |
| Merck Sharp & Dohme LLC | 3 | $60 |
| SCPHARMACEUTICALS INC. | 2 | $53 |
| E.R. Squibb & Sons, L.L.C. | 3 | $44 |
| Alnylam Pharmaceuticals Inc. | 2 | $41 |
| Amgen Inc. | 2 | $32 |
| AstraZeneca Pharmaceuticals LP | 2 | $29 |
Products named: EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX, Opzelura, UPTRAVI, LEQVIO, VERQUVO, FUROSCIX, CAMZYOS, AMVUTTRA.
Industry payments across IL — which companies pay providers there.
